Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Sommerer

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
Transplantation Reviews (Orlando, Fla.)|September 24, 2011
The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimenBarbara Suwelack, Viola Malyar, Martina Koch, et al.
Therapeutic Drug Monitoring|November 23, 2011
Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and olderClaudia Sommerer, Paul Schnitzler, Stefan Meuer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 23, 2026
Age-Related Risk After Kidney Transplantation: A Comprehensive Analysis of Infection Burden, Graft Outcomes, and MortalityIris Schröter, Daniela Schindler, Martin Zeier, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 12, 2021
Bioimpedance analysis is not superior to clinical assessment in determining hydration status: A prospective randomized-controlled trial in a Western dialysis populationClaudia Sommerer, Paul Felten, Johannes Toernig, et al.
Transplantation|January 15, 2008
Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppressionClaudia Sommerer, Thomas Giese, Jan Schmidt, et al.
Clinical Nephrology|December 28, 2016
Correlation between pharmacokinetics of tacrolimus and pharmacodynamics on NFAT-regulated gene expression in stable kidney transplant recipients
Frieder Keller, Claudia Sommerer, Thomas Giese, et al.
Annals of Transplantation|June 22, 2021
Shift in Living Kidney Donor Demographics Over the Past 50 Years in a German Transplant CenterClaudia Sommerer, Zoi Bougioukou, Vasileios L Georgiou, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 11, 2026
Long-Term Outcomes Across Age and Risk Profiles in a Caucasian Living Kidney Donor CohortClaudia Sommerer, Iris Schröter, Nicola Marie Kuhlmann, et al.
Expert Opinion on Pharmacotherapy|April 9, 2013
Current pharmacotherapeutical options for the prevention of kidney transplant rejectionSebastian M Schaefer, Caner Süsal, Claudia Sommerer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2002
The living kidney donor: giving life, avoiding harmClaudia Sommerer, Manfred Wiesel, Jochen Schweitzer-Rothers, et al.
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Transplantation Reviews (Orlando, Fla.)|September 24, 2011
The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimenBarbara Suwelack, Viola Malyar, Martina Koch, et al.
Therapeutic Drug Monitoring|November 23, 2011
Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and olderClaudia Sommerer, Paul Schnitzler, Stefan Meuer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 23, 2026
Age-Related Risk After Kidney Transplantation: A Comprehensive Analysis of Infection Burden, Graft Outcomes, and MortalityIris Schröter, Daniela Schindler, Martin Zeier, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 12, 2021
Bioimpedance analysis is not superior to clinical assessment in determining hydration status: A prospective randomized-controlled trial in a Western dialysis populationClaudia Sommerer, Paul Felten, Johannes Toernig, et al.
Transplantation|January 15, 2008
Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppressionClaudia Sommerer, Thomas Giese, Jan Schmidt, et al.
Clinical Nephrology|December 28, 2016
Correlation between pharmacokinetics of tacrolimus and pharmacodynamics on NFAT-regulated gene expression in stable kidney transplant recipients
Frieder Keller, Claudia Sommerer, Thomas Giese, et al.
Annals of Transplantation|June 22, 2021
Shift in Living Kidney Donor Demographics Over the Past 50 Years in a German Transplant CenterClaudia Sommerer, Zoi Bougioukou, Vasileios L Georgiou, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 11, 2026
Long-Term Outcomes Across Age and Risk Profiles in a Caucasian Living Kidney Donor CohortClaudia Sommerer, Iris Schröter, Nicola Marie Kuhlmann, et al.
Expert Opinion on Pharmacotherapy|April 9, 2013
Current pharmacotherapeutical options for the prevention of kidney transplant rejectionSebastian M Schaefer, Caner Süsal, Claudia Sommerer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2002
The living kidney donor: giving life, avoiding harmClaudia Sommerer, Manfred Wiesel, Jochen Schweitzer-Rothers, et al.
Pageof 16